These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15867972)

  • 1. Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results.
    Rodrigues R; Vazquez CM; Colares JK; Custodio RM; Bonásser Filho F; Souza Ldo R; Gianna MC; Marques CC; Brígido LF
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):97-102. PubMed ID: 15867972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.
    Cavalcanti AM; Lacerda HR; Brito AM; Pereira S; Medeiros D; Oliveira S
    Mem Inst Oswaldo Cruz; 2007 Nov; 102(7):785-92. PubMed ID: 17992369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).
    Machado DM; Fernandes SC; Succi RC; Freire WS; Pannuti CS; Gouveia AB; Levi JE; Diaz RS
    Rev Inst Med Trop Sao Paulo; 2005; 47(1):1-5. PubMed ID: 15729467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study).
    Pellegrin I; Breilh D; Montestruc F; Caumont A; Garrigue I; Morlat P; Le Camus C; Saux MC; Fleury HJ; Pellegrin JL
    AIDS; 2002 Jul; 16(10):1331-40. PubMed ID: 12131209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.
    Røge BT; Katzenstein TL; Nielsen HL; Gerstoft J
    HIV Med; 2003 Jan; 4(1):38-47. PubMed ID: 12534958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.
    Medeiros MS; Arruda EA; Guerrant RL; Brown C; Hammarskjold ML; Rekosh D; Lima AA
    Braz J Infect Dis; 2007 Aug; 11(4):390-4. PubMed ID: 17873990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
    de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
    Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
    Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART.
    Paolucci S; Baldanti F; Maserati R; Castelli F; Suter F; Maggiolo F; Pan A; Gerna G
    Antiviral Res; 2000 Feb; 45(2):101-14. PubMed ID: 10809019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil.
    Toledo PV; Carvalho DS; Romagnoli L; Marcinko G; Cunha CA; Souza MN; Brindeiro R; Queiroz-Telles Fd
    Braz J Infect Dis; 2010; 14(4):360-71. PubMed ID: 20963321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity of human immunodeficiency virus-1 isolates in Paraná, Brazil.
    Toledo PV; Carvalho DS; Rossi SG; Brindeiro R; de Queiroz-Telles F
    Braz J Infect Dis; 2010; 14(3):230-6. PubMed ID: 20835505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco.
    Cavalcanti AM; Brito AM; Salustiano DM; Lima KO; Silva SP; Diaz RS; Lacerda HR
    Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):450-7. PubMed ID: 22666853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of resistance-associated mutations in human immunodeficiency virus type 1-positive individuals failing HAART in Rio de Janeiro, Brazil.
    Varella RB; Ferreira SB; Castro MB; Tavares MD; Zalis MG
    Braz J Infect Dis; 2008 Oct; 12(5):380-4. PubMed ID: 19219276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV genotypic mutation selectively induced by the protease inhibitor nelfinavir at codon 30. Case series and consequences for antiretroviral management].
    Manfredi R; Calza L
    Infez Med; 2002 Sep; 10(3):151-6. PubMed ID: 12704265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.
    Soldi GFR; Ribeiro IC; Ahagon CM; Coelho LPO; Cabral GB; Lopes GISL; Ferreira JLP; Brígido LFM;
    PLoS One; 2019; 14(10):e0223210. PubMed ID: 31574109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary resistance of human immunodeficiency virus type 1 in a reference center in Recife, Pernambuco, Brazil.
    de Medeiros LB; Lacerda HR; Cavalcanti AM; de Albuquerque Mde F
    Mem Inst Oswaldo Cruz; 2006 Dec; 101(8):845-9. PubMed ID: 17293977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.